Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Jan;40(1):22–28. doi: 10.1136/hrt.40.1.22

Haemodynamic effects of atenolol in patients with coronary artery disease.

C Robinson, G Jackson, C Fisk, D Jewitt
PMCID: PMC481969  PMID: 341928

Abstract

The haemodynamic effects of atenolol, a new cardioselective beta-blocking agent, have been studied at rest in 8 patients with coronary artery disease. The drug was administered intravenously in cumulative doses of 0.03, 0.06, and 0.12 mg/kg body weight. A significant decrease in heart rate was associated with a fall in cardiac output. However, this cardiac output fall was not entiely rate dependent, since stroke volume fell significantly both during spontaneous sinus rhythm and when heart rate was maintained constant by atrial pacing. A dose related and significant reduction occurred in left ventricular dP/dt max without significant change in left ventricular filling pressure or mean aortic pressure. Total peripheral resistance at rest rose after atenolol. The haemodynamic findings more closely resemble those which follow intravenous propranolol than those after intravenous practolol in a similar group of patients. These actions of atenolol suggest that it may be a useful agent in the treatment of patients with angina pectoris.

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aström H. Haemodynamic effects of beta-adrenergic blockade. Br Heart J. 1968 Jan;30(1):44–49. doi: 10.1136/hrt.30.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aström H., Vallin H. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974 Dec;36(12):1194–1200. doi: 10.1136/hrt.36.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett A. M., Carter J., Fitzgerald J. D., Hull R., Le Count D. A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol. 1973 Jun;48(2):340P–340P. [PMC free article] [PubMed] [Google Scholar]
  4. Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
  5. Epstein S. E., Braunwald E. Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med. 1966 Nov 17;275(20):1106–contd. doi: 10.1056/NEJM196611172752006. [DOI] [PubMed] [Google Scholar]
  6. Felix R. H., Ive F. A., Dahl M. G. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. doi: 10.1136/bmj.4.5940.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gibson D. G., Balcon R., Sowton E. Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure. Br Med J. 1968 Jul 20;3(5611):161–163. doi: 10.1136/bmj.3.5611.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gibson D. G., Coltart D. J. Haemodynamic effects of practolol. Br Heart J. 1972 Jan;34(1):95–99. doi: 10.1136/hrt.34.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibson D., Sowton E. Effects of I.C.I. 50172 in man during erect exercise. Br Med J. 1968 Jan 27;1(5586):213–215. doi: 10.1136/bmj.1.5586.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gibson D., Sowton E. The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis. 1969 Jul;12(1):16–39. doi: 10.1016/0033-0620(69)90033-4. [DOI] [PubMed] [Google Scholar]
  11. Hamer J., Sowton E. Cardiac output after beta-adrenergic blockade in ischaemic heart disease. Br Heart J. 1965 Nov;27(6):892–895. doi: 10.1136/hrt.27.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harry J. D. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man. Postgrad Med J. 1977;53 (Suppl 3):65–69. [PubMed] [Google Scholar]
  13. Jewitt D. E., Burgess P. A., Shillingford J. P. The circulatory effects of practolol (ICI 50172) in patients with acute myocardial infarction. Cardiovasc Res. 1970 Apr;4(2):188–193. doi: 10.1093/cvr/4.2.188. [DOI] [PubMed] [Google Scholar]
  14. Jewitt D. E., Mercer C. J., Shillingford J. P. Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction. Lancet. 1969 Aug 2;2(7614):227–230. doi: 10.1016/s0140-6736(69)90001-4. [DOI] [PubMed] [Google Scholar]
  15. Lesch M., Gorlin R. Pharmacological therapy of angina pectoris. Mod Concepts Cardiovasc Dis. 1973 Feb;42(2):5–10. [PubMed] [Google Scholar]
  16. Macdonald A. G., McNeill R. S. A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol. Br J Anaesth. 1968 Jul;40(7):508–510. doi: 10.1093/bja/40.7.508. [DOI] [PubMed] [Google Scholar]
  17. Marlin G. E., Kumana C. R., Kaye C. M., Smith D. M., Turner P. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol. 1975 Apr;2(2):151–157. doi: 10.1111/j.1365-2125.1975.tb01570.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mason D. T., Spann J. F., Jr, Zelis R. Quantification of the contractile state of the intact human heart. Maximal velocity of contractile element shortening determined by the instantaneous relation between the rate of pressure rise and pressure in the left ventricle during isovolumic systole. Am J Cardiol. 1970 Sep;26(3):248–257. doi: 10.1016/0002-9149(70)90791-5. [DOI] [PubMed] [Google Scholar]
  19. McDevitt D. G., Brown H. C., Carruthers S. G., Shanks R. G. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther. 1977 May;21(5):556–566. doi: 10.1002/cpt1977215556. [DOI] [PubMed] [Google Scholar]
  20. PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Powles R., Shinebourne E., Hamer J. Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy. Thorax. 1969 Sep;24(5):616–618. doi: 10.1136/thx.24.5.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sowton E., Balcon R., Cross D., Frick H. Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease. Br Med J. 1968 Jan 27;1(5586):215–216. doi: 10.1136/bmj.1.5586.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vilsvik J. S., Schaanning J. Effect of atenolol on ventilatory and cardiac function in asthma. Br Med J. 1976 Aug 21;2(6033):453–455. doi: 10.1136/bmj.2.6033.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. doi: 10.1136/bmj.1.5958.595. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES